Safety of everolimus plus exemestane in patients with hormone-receptor-positive, HER2-negative locally advanced or metastatic breast cancer: results of phase IIIb BALLET trial in Spain
Titel:
Safety of everolimus plus exemestane in patients with hormone-receptor-positive, HER2-negative locally advanced or metastatic breast cancer: results of phase IIIb BALLET trial in Spain
Auteur:
Ciruelos, E. Vidal, M. Martínez de Dueñas, E. Martínez-Jáñez, N. Fernández, Y. García-Sáenz, J. A. Murillo, L. Carabantes, F. Beliera, A. Fonseca, R. Gavilá, J.